ELLANSÉ™ S 2x1 ml – Collagen-Stimulating Dermal Filler for Natural and Long-Lasting Results
 
ELLANSÉ™ S 2x1 ml is an advanced collagen-stimulating dermal filler developed by Sinclair Pharma (United Kingdom).
Formulated with polycaprolactone (PCL) microspheres suspended in a carboxymethylcellulose (CMC) gel, it delivers both immediate volumizing effects and progressive collagen regeneration, restoring youthful skin tone, elasticity, and structure.
Ellansé™ S provides natural and long-lasting results lasting up to 12 months, making it the perfect choice for patients seeking both instant and biological skin rejuvenation.
 
Product Overview
Ellansé™ S works through a dual-action mechanism:
Immediate correction from its CMC gel carrier, restoring volume and contour.
Long-term stimulation of Type I collagen production through PCL microspheres, improving dermal structure and elasticity.
It’s the shortest-duration variant in the Ellansé range, ideal for first-time patients or those seeking 1-year collagen-stimulation treatments.
 
Technology & Composition
Technology: PCL-based collagen stimulator (Resorbable microsphere technology)
Composition:
• 30% Polycaprolactone (PCL) – smooth, spherical, bioresorbable microspheres (25–50 µm)
• 70% Carboxymethylcellulose (CMC) – gel carrier providing immediate volume
Mode of Action: Immediate volumization + long-term neocollagenesis
Packaging (Content):
• 2 prefilled syringes x 1 ml each
• 4 sterile needles (27G ¾”)
• Product labels and professional instructions
 
Indications & Treatment Areas
ELLANSÉ™ S is designed for the correction of wrinkles, facial folds, and volume loss, while simultaneously improving skin texture, firmness, and radiance through collagen stimulation.
 
Recommended Treatment Areas:
Cheeks and cheekbones
Nasolabial folds
Jawline definition
Chin contouring
(Not suitable for lips or periorbital regions.)
 
Clinical Benefits
Immediate Lift & Volume: Restores facial contours instantly.
Collagen Biostimulation: Stimulates natural Type I collagen production for long-term improvement.
Smooth Integration: Provides even distribution and natural results.
Long-Lasting Effects: Results typically last up to 12 months.
Safe & Bioabsorbable: Fully biocompatible and CE-certified medical device.
 
Treatment Protocol
Injection Depth: Deep dermis or subcutaneous layer
Techniques: Linear retrotracing, fanning, or cross-hatching (based on indication)
Treatment Frequency: Single session; maintenance recommended every 12 months
Procedure Duration: Approximately 30 minutes
Post-Treatment Care: Avoid pressure, massage, or strong cosmetics for 48 hours
 
Duration of Results
Results are visible immediately after injection, with continued improvement as new collagen forms over 3–6 months.
Immediate Volume: CMC carrier provides instant lift
Long-Term Regeneration: PCL microspheres promote neocollagenesis
Longevity: Typically up to 1 year, depending on patient metabolism and lifestyle
 
Manufacturer & Regulatory Information
Manufactured by Sinclair Pharma Ltd. (United Kingdom)
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
ISO 13485 certified manufacturer
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
 
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are intended strictly for professional use.
We insist that these treatments be administered only by licensed medical and healthcare professionals, ensuring the highest standards of safety, precision, and patient care.